- Life expectancy for men in the U.S. falls to 73 years — six years less than for women.
- Noah Smith lauds Singapore but neglects to mention Medisave accounts.
- What discount rate should be used in evaluating changes in health policies?
- Should medical screenings be based on cost/benefit analysis or on the patient’s willingness to pay?
- A tribute to Vernon Smith – long time friend of the Goodman Institute.
- Does the case for a free society depend on the existence of free will?
Included in Friday Links (November 10) was the title, “Would coverage for gene therapies make employer-based health insurance unaffordable?” That raises an important question: How much should employers (and employees) be required to pay for hyper-expensive therapies very few people need? A related question: should the purpose of employee health coverage be to recruit and retain workers or fund rare disease research and therapies?